John A Nguyen, PhD MBA

Innovating in health, tech, and beyond | From scientist to strategist to startups and product

📍 Australia🔄 Updated September 2026💼 1 investments📅 1 years investing🗓 Last invested Nov 2025
VC🌍 AustraliaInvested this year
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
1y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Experience · 6 entries
All (6)
Investments (1)
Founder (3)
2025
Founder
Aug 2025
A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered
Entrepreneur in Residence
2025
Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.
2023
Co-Founder
2023
Award-winning innovation developed by a multidisciplinary team of engineers, researchers, clinical partners, and commercial experts. Backed by the University of Melbourne, TRAM (Translating Research at Melbourne), Flinders University, MedTech Actuator, StartSpace Study Melbourne, and leading healthcare advisors. Sano Technologies is reshaping body composition assessment and disease diagnostics through our disruptive technology capable of revealing localised composition imbalances and patterns in a four-dimensional and highly visual way. Researchers, clinicians and patients gain insights into high-definition composition data that existing approaches cannot provide. This information guides better treatments and empowers decision-makers. The first application of our innovation is taking the guesswork out of lymphoedema care by revealing localised fluid build-up and tissue composition.
2018
Consultant - Strategy Development
2018
Advention is an independent strategy advisory group with eighty professionals operating globally in an integrated manner through its fully-owned offices in Dubai, London, New York, Shanghai, Paris and Vancouver. Advention was founded by a group of senior partners with successful experiences in first-tier strategy consulting firms as well as leading corporations and entrepreneurial ventures. The firm is engaged in strategy consulting and transaction support. Advention’s strategy consulting work includes corporate and business unit strategy, growth strategy and performance improvement. Transaction support work includes buy-side and sell side strategic reviews. Its client portfolio includes large corporations, private equity firms and small/medium-sized businesses. Advention has developed expertises in key industry clusters, including: Consumer Goods and Retail, Luxury, Media & Entertainment, Pharmaceuticals & Healthcare, Industry & Engineering, Digital, Telecommunications & High-Tech, Defense & Aerospace, Utilities & Services and Financial Services. For further information, please contact Alban Neveux (Group CEO): • E-mail: alban.neveux@adventionbp.com • Fixed: +33 1 53 43 88 57 • Mobile: +33 6 10 94 33 39 • Skype: albanneveux • WeChat: AlbanNeveux
Show all 6 entries ↓